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Ureteroarterial fistula
Raghu L. Motaganahalli, MD, FRCS, FACS,a Alok Gupta, MD,a Virgillio George, MD,b and
Stephen Beck, MD,c Indianapolis, IndThe patient was a 54-year-old man with an aortobifemoral bypass (AFB) for occlusive
disease done in 2007. Three years later, he had an excision of the infected AFB graft with
in situ reconstruction using a cryopreserved vein as well as ureteral stent placement. He
was lost for follow-up for 4 months when he presented at an outside hospital with
massive hematuria. A urologist at the outside facility noted hematuria from the left ureter
orifice. Additional bleeding was encountered during attempted removal of stent. The
patient was transferred to our facility with an inflated balloon for tamponade in the left
ureter.
A 12F sheath was placed into the left limb of the cryopreserved AFB graft via a left
femoral artery exposure. Angiographic evaluation with the deflated ureteric balloon
confirmed ureteroarterial fistula (A). An iliac extension stent graft of 16  9.5 cm was
deployed across the fistula (B) with a revision of the ureteric stent. During this admission,
he also had an incidental diagnosis of rectal cancer. He was planned for an abdomino-
perineal resection. He continued to have recurrent urinary tract infections (UTIs)
despite being on antibiotics. An indium-labeled white cell scan suggested no stent graft
infection. Due to persistent UTIs, the iliac stent graft was explanted at the time of
abdominoperineal resection. The patient had intense inflammation around the ureter
and bypass graft (C). The fistula was disconnected (D) and the primary ureteral
reconstruction was performed over a stent. Vascular reconstruction was performed with
an interposition cryopreserved artery. An omental pedicle was placed between the ureter
and left limb of the bypass graft.
Ureteroarterial fistula is a rare life-threatening complication that may result with
degeneration of the ureteral wall due to disruption of the arterial supply by radiation,
pelvic surgery, vascular surgical procedures, and pressure necrosis by prolonged ureteral
stent placement.1 Symptoms include intermittent to life-threatening hematuria. Treat-
ment includes excision of the involved arterial segment with extra-anatomic bypass or
primary repair. Stent grafts are increasingly used to control life-threatening hematuria
followed by delayed open surgical revision to reduce the risk for recurrent UTIs,
bleeding, and stent graft complications.2
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